TOP STORIES
Turing Pharmaceuticals said it will offer reductions of up to 50 percent off its $750-a-pill price to hospitals, which handle about 80 percent of cases of toxoplasmosis encephalitis. – Reuters
Think of the Pfizer-Allergan deal as a bad food slogan: Bad for Ireland, too! – Wall Street Journal
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
A 15-year-old boy has died of Ebola in Liberia, the first fatality from the virus for months in the country that was declared free of the disease in September. — Reuters
LIFE SCIENCES
Novo Nordisk said all of its global manufacturing facilities will run on electricity generated from renewable sources by 2020. — FiercePharmaManufacturing
University College London has announced that it is forming a biopharma company focused on gene therapies to treat eye diseases that cause blindness. — PharmaTimes
PAYERS/PROVIDERS
Many primary care practitioners will make less money in 2016 because of the expiration of a health law program that has been paying them a 10 percent bonus for caring for Medicare patients. — Kaiser Health News
This could make for more awkward/terrifying conversations over the dinner table this holiday: In 2004, the Surgeon General declared Thanksgiving to be National Family History Day – a day to talk about health problems that run in the family. This year, Delos “Toby” Cosgrove, MD, president and CEO of Cleveland Clinic is urging Americans to participate. — Becker’s Hospital Review
TECH
CareCube, a new product from Quietyme will allow hospitalized patients to call for a nurse, food service, hospitality or more just by changing the orientation of a box about the size and shape of a Rubik’s Cube. — MobiHealthNews
POLITICS
The FDA approved Fluad, the first seasonal influenza vaccine containing an adjuvant. Fluad, a trivalent vaccine produced from three influenza virus strains (two subtype A and one type B), is approved for the prevention of seasonal influenza in people 65 years of age and older. — FDA
A LITTLE EXTRA
It’s been confirmed: Apple has acquired Faceshift, a startup based in Zurich that has developed technology to create animated avatars and other figures that capture a person’s facial expressions in real time. — TechCrunch
Photo: Flickr user NIAID